Media Coverage

RXTransparent is in the news.

4-16-18 Dwight deVera Featured in Becker's Hospital Review

Dwight deVera, founder and CEO of RXTransparent, is featured in Becker’s Hospital Review on “Blockchain Securing the Healthcare Supply Chain”

2-11-17 Interview with CEO Dwight deVera and The Entrepreneurs Netwrok Radio Host Rick Anthony

Join Rick Anthony, radio host from The Entrepreneurs Network and CEO Dwight deVera as they discuss starting a busines, RXTransparent and it’s quick success.


Helping hospitals track counterfeit drugs is this start-up's Rx -

RXTransparent featured in the Sunday, January 1st Philadelphia Inquirer.  CEO Dwight deVera discusses how RXTransparent fulfills the void Pharmacy Departments need to comply with the FDA – Drug Supply Chain Security Act.

Read the article here.

Dwight deVera Featured in Inc. Magazine

On November 28, 2016, The Forerunner Group president & CEO, Dwight deVera, was recently asked by Inc. Magazine to share the daily habit that has lead to his success:

15. Help the people around you succeed.
“I put my team’s needs before mine. By giving people the freedom and resources to do what they need to do, and by creating an environment where they can succeed, we all get to a better place as an organization.”

–Dwight deVera, president and CEO of Forerunner Group, provider of RXTransparent, an end-to-end drug supply chain compliance solution for the healthcare industry.

Read the article here.

Dwight deVera headshot

Dwight deVera Featured in Thanksgiving Gratitude List Along with Sharks, Lori Greiner and Daymond John

On November 23, 2016, a quote from The Forerunner Group CEO and President, Dwight deVera, was published by This article focused on what 25 entrepreneurs were thankful for in their careers.

Read the article here.

IT Firm Enters DSCSA Field from the Hospital Pharmacy Direction

On October 23, 2016, an interview with The Forerunner Group CEO, Dwight deVera, was published by Pharmaceutial Commerce. The article focused on the Premier GPO contract approval for the company’s Drug Supply Chain Security Act solution, RXTransparent. Mr. deVera is finding his company in demand with other hospital pharmacy directors who have heard of the implementation.

Read the article here.


Premier Inc. Selects RXTransparent Compliance Solution

The news that RXTransparent has been selected by healthcare GPO Premier Inc. to address DSCSA compliance for its alliance of 3,750 U.S. hospitals and 130,000 other providers, was published by and on October 20th and 21st respectively. The press release focused on RXTransparent as the first drug supply chain tracking solution to go “beyond the loading dock,” now available via preferred contract pricing to Premier members.

Read the articles here: and

Tracking Software Facilitates Pharmaceutical Recalls

On October 11, 2016, an interview with The Forerunner Group CEO, Dwight deVera, was published in Supply Chain Dive.

The article focused on Forerunner’s first product launch, RXTransparent, a platform developed in response to the 2013 Drug Supply Chain Security Act (DSCSA), a law passed to protect consumers from the effects of counterfeit medication.

Read the article here.

Stellar Startups

Recognizing the Stellar StartUps Among Us

On September 9, 2016, The Forerunner Group was listed as a finalist in the Stellar Startups competition, an event sponsored by Philadelphia Media Network, that held an awards banquet at the Pennovation Center on September 9, 2016.

The Forerunner Group was one of 20 startups selected from 100 applicants that applied in one of six categories: college students, health care, just plain cool idea, products/services, technology and women/minority entrepreneurs.

Featured was Forerunner’s first product launch, RXTransparent, developed to protect American consumers from the effects of counterfeit medication.

Read the article here.

For a list of the 20 finalists, click here.

RXTransparent is more than just a compliance solution.

RXTransparent offers value-added functions designed to help pharmacies make money and save money.